Bioxytran BIXT Cash Flow Statement (2010-2026)

OTC BIXT
$0.02 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT
Reported Financials

Bioxytran Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Bioxytran reported cash from operations of -$0.35M and free cash flow of -$0.35M for the quarter ended Jun 2026, down 377.9% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-0.61M-1.00M-0.96M-0.63M-0.20M-0.87M-0.82M-1.45M-1.13M-1.17M-0.57M-0.66M-0.39M-0.75M-1.35M0.04M-0.28M-0.52M-2.07M-0.62M
Depreciation and DepletionDep. & Depletion
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
911.00911.00911.00911.00514.000.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M
Amortization of Deferred ChargesAmort. Deferred Charges
0.03M0.03M0.09M0.04M0.17M0.01M0.03M0.62M
Depreciation & Amortization (CF)Dep. & Amort.
Share-based CompensationStock Comp.
844.00-0.24M0.02M0.05M0.07M0.04M850.00360.000.08M0.01M0.17M0.01M0.01M0.01M0.09M0.02M-0.01M0.06M0.04M0.03M
Gains from Investment SecuritiesGains Investment
-0.80M0.31M0.26M0.02M-0.07M0.11M
Other non-cash itemsOther Non-Cash
0.04M0.16M795.00
Non-cash ItemsNon-Cash Items
0.29M
Change in Working Capital
Change in ReceivablesChange Receivables
Change in InventoryChange Inventory
Change in Account PayablesChange Payables
Change in Accured ExpensesChange Accured Exp.
0.10M0.89M-0.11M0.04M-0.22M0.41M0.35M-0.46M-0.10M-0.01M0.21M0.50M-0.60M0.15M0.16M0.14M0.39M-0.20M0.22M0.13M
Change in Other Operating AssetsOther Assets Change
-1.00-0.50M0.00M
Change in Other Operating LiabilitiesOther Liabilities Change
0.34M-0.32M0.27M0.27M-0.60M0.25M0.27M1.39M0.61M0.00M
Other Working Capital ChangesOther WC Changes
0.34M0.18M0.27M0.27M-0.60M0.25M0.27M1.39M0.61M0.00M0.00M
Cash from OperationsCash from Ops.
-0.14M-0.14M-0.69M-0.24M-0.72M-0.15M-0.19M-0.15M-0.34M-0.09M-0.11M-0.07M-0.07M-0.13M-0.17M-0.07M-0.05M-0.24M-0.24M-0.35M
Investing Activities
Capital ExpendituresCapex
Change in Property, Plant and EquipmentChange in PP&E
Change in IntangiblesChange Intangibless
0.03M0.02M115.000.01M0.00M0.00M0.02M0.01M0.01M0.01M-693.000.01M0.01M15.000.01M0.00M0.01M0.01M0.01M
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-0.03M-0.02M-115.00-0.01M0.00M0.00M-0.02M-0.01M-0.01M-0.01M693.00-0.01M-0.01M-15.00-0.01M0.00M-0.01M-0.01M-0.01M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
1.38M1.05M0.06M1.05M
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
1.38M1.05M0.06M1.05M
Short-Term Debt issuancesST Debt Issuance
0.04M0.01M0.01M0.01M
Current Debt
0.04M0.01M0.01M0.01M
Net Debt Issuances and RepaymentsNet Debt Issuance
1.38M1.05M0.10M0.01M1.05M0.01M0.01M
Change in Capital Stock
Common Stock IssuedStock Issued
0.08M0.05M0.07M0.39M0.00M0.06M0.72M0.24M0.07M
Net Shares Issued and RepurchasedNet Shares Issued
0.08M0.05M0.07M0.39M0.00M0.06M0.72M0.24M0.07M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.08M0.05M0.07M0.39M0.00M0.06M0.72M0.24M0.07M
Other financing activitiesOther financing
0.05M
Cash from Financing ActivitiesCash from Financing
1.38M0.60M0.08M0.05M0.07M0.39M0.05M0.10M0.07M0.11M0.11M0.17M0.08M0.06M0.74M0.20M0.07M
Additional items
Change in Cash
-0.14M-0.17M0.67M-0.24M-0.13M-0.08M-0.14M-0.11M0.04M-0.05M-0.02M0.00M0.02M-0.03M-806.000.00M0.01M0.50M-0.05M-0.29M
Ending Cash Balance
0.24M0.07M0.74M0.50M0.37M0.30M0.15M0.05M0.08M0.03M0.01M0.01M0.03M0.01M0.00M0.00M0.01M0.51M0.46M0.18M
Free Cash FlowFCF
-0.14M-0.14M-0.69M-0.24M-0.72M-0.15M-0.19M-0.15M-0.34M-0.09M-0.11M-0.07M-0.07M-0.13M-0.17M-0.07M-0.05M-0.24M-0.24M-0.35M
Net Cash FlowNCF
-0.14M-0.17M0.67M-0.24M-0.13M-0.08M-0.14M-0.11M0.04M-0.05M-0.02M0.00M0.02M-0.03M-806.000.00M0.01M0.50M-0.05M-0.29M
Interest Paid
0.03M0.05M0.16M0.03M
Income Taxes PaidTaxes Paid

Bioxytran Cash Flow Statement API

Pull Bioxytran's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BIXT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY